Related references
Note: Only part of the references are listed.Surgical Treatments of Hepatobiliary Cancers
Ganesh Gunasekaran et al.
HEPATOLOGY (2021)
Integration of radiotherapy with anti-PD-1 antibody for the treatment of intrahepatic or hilar cholangiocarcinoma: reflection from four cases
Qianqian Zhao et al.
CANCER BIOLOGY & THERAPY (2021)
Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma
Gauthier Delaby et al.
ABDOMINAL RADIOLOGY (2021)
Current standards and future perspectives in adjuvant treatment for biliary tract cancers
Angela Lamarca et al.
CANCER TREATMENT REVIEWS (2020)
The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
Qiao Ke et al.
PLOS ONE (2020)
A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma
Bixin Ren et al.
RADIATION ONCOLOGY (2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial
Vivek Subbiah et al.
LANCET ONCOLOGY (2020)
Anti-PD-1 Immunotherapy and Radiotherapy for Stage IV Intrahepatic Cholangiocarcinoma: A Case Report
Ze-Long Liu et al.
FRONTIERS IN MEDICINE (2020)
Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: ameta-analysis and systematic review
Jeongshim Lee et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
Shosei Shimizu et al.
RADIATION ONCOLOGY (2019)
Predictors of adjuvant treatment and survival in patients with intrahepatic cholangiocarcinoma who undergo resection
Grace C. Lee et al.
AMERICAN JOURNAL OF SURGERY (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges
Ijin Joo et al.
RADIOLOGY (2018)
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
Tatsuaki Sumiyoshi et al.
WORLD JOURNAL OF SURGERY (2018)
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Fernanda G. Herrera et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Cholangiocarcinoma: Current Knowledge and New Developments
Boris Blechacz
GUT AND LIVER (2017)
Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8+ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis
Yu Jin Lim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study
Gemma Gatta et al.
LANCET ONCOLOGY (2017)
Nodal areas of potential geographic error in adjuvant radiotherapy for biliary tract cancer
Joanna Socha et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
Jang Han Jung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Cholangiocarcinoma
Michela Squadroni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies
Ilaria Marinelli et al.
ANTICANCER RESEARCH (2017)
A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer
S. Kobayashi et al.
EJSO (2017)
A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer
Kyong Joo Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis
Randa Tao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S. Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
Michael B. Bernstein et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer
Shogo Kobayashi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Edgar Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Proton beam therapy for unresectable intrahepatic cholangiocarcinoma
Ayako Ohkawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies
Eric I. Marks et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2015)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies
Marta Bonet Beltran et al.
CANCER TREATMENT REVIEWS (2012)
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen et al.
GASTROENTEROLOGY (2012)
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Anne M. Horgan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Radiation as an immunological adjuvant: current evidence on dose and fractionation
Sandra Demaria et al.
FRONTIERS IN ONCOLOGY (2012)
Comparative Analysis of Resection and Liver Transplantation for Intrahepatic and Hilar Cholangiocarcinoma
Johnny C. Hong et al.
ARCHIVES OF SURGERY (2011)
Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience
Francesco Antonio Polistina et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients
Yi-Xing Chen et al.
BMC CANCER (2010)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
IMPACT FACTORS FOR MICROINVASION IN INTRAHEPATIC CHOLANGIOCARCINOMA A POSSIBLE SYSTEM FOR DEFINING CLINICAL TARGET VOLUME
Ai-Hong Bi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic Correlation
Yong Eun Chung et al.
RADIOGRAPHICS (2009)
Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis
Masashi Mizumoto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct
Michael A. Hughes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Liver transplantation for unresectable perihilar cholangiocarcinoma
JK Heimbach et al.
SEMINARS IN LIVER DISEASE (2004)
Pathological appraisal of lines of resection for bile duct carcinoma
T Ebata et al.
BRITISH JOURNAL OF SURGERY (2002)
Partial irradiation of the liver
LA Dawson et al.
SEMINARS IN RADIATION ONCOLOGY (2001)
Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma
I De Vreede et al.
LIVER TRANSPLANTATION (2000)
Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma
T Todoroki et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
